Global Neuromodulation Devices and Implantable Infusion Pumps Market Growth 2023-2029

Publisher Name :
Date: 04-Jan-2023
No. of pages: 105

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

LPI (LP Information)' newest research report, the "Neuromodulation Devices and Implantable Infusion Pumps Industry Forecast" looks at past sales and reviews total world Neuromodulation Devices and Implantable Infusion Pumps sales in 2022, providing a comprehensive analysis by region and market sector of projected Neuromodulation Devices and Implantable Infusion Pumps sales for 2023 through 2029. With Neuromodulation Devices and Implantable Infusion Pumps sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuromodulation Devices and Implantable Infusion Pumps industry.

This Insight Report provides a comprehensive analysis of the global Neuromodulation Devices and Implantable Infusion Pumps landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neuromodulation Devices and Implantable Infusion Pumps portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Neuromodulation Devices and Implantable Infusion Pumps market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuromodulation Devices and Implantable Infusion Pumps and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuromodulation Devices and Implantable Infusion Pumps.

The global Neuromodulation Devices and Implantable Infusion Pumps market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.

Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.

In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Neuromodulation Devices and Implantable Infusion Pumps market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

- Spinal Cord Stimulation

- Deep Brain Stimulation

- Sacral Nerve Stimulation

- Vagal Nerve Stimulation

- Gastric Stimulation

- Transcranial Magnetic Stimulation

- Transcutaneous Electrical Stimulation

- Other

Segmentation by application

- Parkinson's Disease

- Epilepsy

- Pain

- Other

The below companies that are profiled

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

- Medtronic

- Boston Scientific Corporation

- St. Jude Medical

- Synapse Biomedical

- Nevro Corporation

- Neuropace

- Cyberonics

- Autonomic Technologies

- Avery Biomedical

- Greatbatch Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Neuromodulation Devices and Implantable Infusion Pumps market?

What factors are driving Neuromodulation Devices and Implantable Infusion Pumps market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Neuromodulation Devices and Implantable Infusion Pumps market opportunities vary by end market size?

How does Neuromodulation Devices and Implantable Infusion Pumps break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Global Neuromodulation Devices and Implantable Infusion Pumps Market Growth 2023-2029

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Neuromodulation Devices and Implantable Infusion Pumps by Country/Region, 2018, 2022 & 2029
2.2 Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
2.2.1 Spinal Cord Stimulation
2.2.2 Deep Brain Stimulation
2.2.3 Sacral Nerve Stimulation
2.2.4 Vagal Nerve Stimulation
2.2.5 Gastric Stimulation
2.2.6 Transcranial Magnetic Stimulation
2.2.7 Transcutaneous Electrical Stimulation
2.2.8 Other
2.3 Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
2.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2018-2023)
2.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2018-2023)
2.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2018-2023)
2.4 Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
2.4.1 Parkinson's Disease
2.4.2 Epilepsy
2.4.3 Pain
2.4.4 Other
2.5 Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
2.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Market Share by Application (2018-2023)
2.5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Application (2018-2023)
2.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2018-2023)
3 Global Neuromodulation Devices and Implantable Infusion Pumps by Company
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Breakdown Data by Company
3.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Company (2018-2023)
3.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2018-2023)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Company (2018-2023)
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2018-2023)
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2018-2023)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company
3.4 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Location Distribution
3.4.2 Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Neuromodulation Devices and Implantable Infusion Pumps by Geographic Region
4.1 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Geographic Region (2018-2023)
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country/Region (2018-2023)
4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Sales by Country/Region (2018-2023)
4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue by Country/Region (2018-2023)
4.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.4 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
4.6 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Growth
5 Americas
5.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
5.1.1 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2018-2023)
5.1.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2018-2023)
5.2 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
5.3 Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
6.1.1 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2018-2023)
6.1.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2018-2023)
6.2 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
6.3 APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps by Country
7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2018-2023)
7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2018-2023)
7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps by Country
8.1.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2018-2023)
8.1.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2018-2023)
8.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
8.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.3 Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
10.4 Industry Chain Structure of Neuromodulation Devices and Implantable Infusion Pumps
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
11.3 Neuromodulation Devices and Implantable Infusion Pumps Customer
12 World Forecast Review for Neuromodulation Devices and Implantable Infusion Pumps by Geographic Region
12.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Forecast by Region
12.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Region (2024-2029)
12.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Type
12.7 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Information
13.2.2 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Boston Scientific Corporation Main Business Overview
13.2.5 Boston Scientific Corporation Latest Developments
13.3 St. Jude Medical
13.3.1 St. Jude Medical Company Information
13.3.2 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 St. Jude Medical Main Business Overview
13.3.5 St. Jude Medical Latest Developments
13.4 Synapse Biomedical
13.4.1 Synapse Biomedical Company Information
13.4.2 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Synapse Biomedical Main Business Overview
13.4.5 Synapse Biomedical Latest Developments
13.5 Nevro Corporation
13.5.1 Nevro Corporation Company Information
13.5.2 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Nevro Corporation Main Business Overview
13.5.5 Nevro Corporation Latest Developments
13.6 Neuropace
13.6.1 Neuropace Company Information
13.6.2 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Neuropace Main Business Overview
13.6.5 Neuropace Latest Developments
13.7 Cyberonics
13.7.1 Cyberonics Company Information
13.7.2 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cyberonics Main Business Overview
13.7.5 Cyberonics Latest Developments
13.8 Autonomic Technologies
13.8.1 Autonomic Technologies Company Information
13.8.2 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Autonomic Technologies Main Business Overview
13.8.5 Autonomic Technologies Latest Developments
13.9 Avery Biomedical
13.9.1 Avery Biomedical Company Information
13.9.2 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Avery Biomedical Main Business Overview
13.9.5 Avery Biomedical Latest Developments
13.10 Greatbatch Medical
13.10.1 Greatbatch Medical Company Information
13.10.2 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
13.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Greatbatch Medical Main Business Overview
13.10.5 Greatbatch Medical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Neuromodulation Devices and Implantable Infusion Pumps Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Neuromodulation Devices and Implantable Infusion Pumps Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Spinal Cord Stimulation
Table 4. Major Players of Deep Brain Stimulation
Table 5. Major Players of Sacral Nerve Stimulation
Table 6. Major Players of Vagal Nerve Stimulation
Table 7. Major Players of Gastric Stimulation
Table 8. Major Players of Transcranial Magnetic Stimulation
Table 9. Major Players of Transcutaneous Electrical Stimulation
Table 10. Major Players of Other
Table 11. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2018-2023) & (Unit)
Table 12. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2018-2023)
Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2018-2023) & ($ million)
Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2018-2023)
Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Type (2018-2023) & (USD/Unit)
Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2018-2023) & (Unit)
Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2018-2023)
Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2018-2023)
Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2018-2023)
Table 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Application (2018-2023) & (USD/Unit)
Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Company (2018-2023) & (Unit)
Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company (2018-2023)
Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2018-2023) ($ Millions)
Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company (2018-2023)
Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sale Price by Company (2018-2023) & (USD/Unit)
Table 26. Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Producing Area Distribution and Sales Area
Table 27. Players Neuromodulation Devices and Implantable Infusion Pumps Products Offered
Table 28. Neuromodulation Devices and Implantable Infusion Pumps Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Geographic Region (2018-2023) & (Unit)
Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share Geographic Region (2018-2023)
Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Geographic Region (2018-2023) & ($ millions)
Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Geographic Region (2018-2023)
Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Country/Region (2018-2023) & (Unit)
Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country/Region (2018-2023)
Table 37. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country/Region (2018-2023) & ($ millions)
Table 38. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country/Region (2018-2023)
Table 39. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2018-2023) & (Unit)
Table 40. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2018-2023)
Table 41. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2018-2023) & ($ Millions)
Table 42. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2018-2023)
Table 43. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2018-2023) & (Unit)
Table 44. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2018-2023) & (Unit)
Table 45. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2018-2023) & (Unit)
Table 46. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2018-2023)
Table 47. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2018-2023) & ($ Millions)
Table 48. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2018-2023)
Table 49. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2018-2023) & (Unit)
Table 50. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2018-2023) & (Unit)
Table 51. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2018-2023) & (Unit)
Table 52. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2018-2023)
Table 53. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2018-2023) & ($ Millions)
Table 54. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2018-2023)
Table 55. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2018-2023) & (Unit)
Table 56. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2018-2023) & (Unit)
Table 57. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2018-2023) & (Unit)
Table 58. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2018-2023)
Table 59. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2018-2023) & ($ Millions)
Table 60. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2018-2023)
Table 61. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2018-2023) & (Unit)
Table 62. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2018-2023) & (Unit)
Table 63. Key Market Drivers & Growth Opportunities of Neuromodulation Devices and Implantable Infusion Pumps
Table 64. Key Market Challenges & Risks of Neuromodulation Devices and Implantable Infusion Pumps
Table 65. Key Industry Trends of Neuromodulation Devices and Implantable Infusion Pumps
Table 66. Neuromodulation Devices and Implantable Infusion Pumps Raw Material
Table 67. Key Suppliers of Raw Materials
Table 68. Neuromodulation Devices and Implantable Infusion Pumps Distributors List
Table 69. Neuromodulation Devices and Implantable Infusion Pumps Customer List
Table 70. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2024-2029) & (Unit)
Table 71. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2024-2029) & (Unit)
Table 73. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region (2024-2029) & (Unit)
Table 75. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region (2024-2029) & ($ millions)
Table 76. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2024-2029) & (Unit)
Table 77. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Country (2024-2029) & (Unit)
Table 79. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Country (2024-2029) & ($ millions)
Table 80. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2024-2029) & (Unit)
Table 81. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 82. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2024-2029) & (Unit)
Table 83. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 84. Medtronic Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 85. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 86. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Medtronic Main Business
Table 88. Medtronic Latest Developments
Table 89. Boston Scientific Corporation Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 90. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 91. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Boston Scientific Corporation Main Business
Table 93. Boston Scientific Corporation Latest Developments
Table 94. St. Jude Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 95. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 96. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. St. Jude Medical Main Business
Table 98. St. Jude Medical Latest Developments
Table 99. Synapse Biomedical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 100. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 101. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Synapse Biomedical Main Business
Table 103. Synapse Biomedical Latest Developments
Table 104. Nevro Corporation Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 105. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 106. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Nevro Corporation Main Business
Table 108. Nevro Corporation Latest Developments
Table 109. Neuropace Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 110. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 111. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Neuropace Main Business
Table 113. Neuropace Latest Developments
Table 114. Cyberonics Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 115. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 116. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Cyberonics Main Business
Table 118. Cyberonics Latest Developments
Table 119. Autonomic Technologies Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 120. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 121. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Autonomic Technologies Main Business
Table 123. Autonomic Technologies Latest Developments
Table 124. Avery Biomedical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 125. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 126. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Avery Biomedical Main Business
Table 128. Avery Biomedical Latest Developments
Table 129. Greatbatch Medical Basic Information, Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Base, Sales Area and Its Competitors
Table 130. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolios and Specifications
Table 131. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Greatbatch Medical Main Business
Table 133. Greatbatch Medical Latest Developments
List of Figures
Figure 1. Picture of Neuromodulation Devices and Implantable Infusion Pumps
Figure 2. Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Growth Rate 2018-2029 (Unit)
Figure 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Spinal Cord Stimulation
Figure 10. Product Picture of Deep Brain Stimulation
Figure 11. Product Picture of Sacral Nerve Stimulation
Figure 12. Product Picture of Vagal Nerve Stimulation
Figure 13. Product Picture of Gastric Stimulation
Figure 14. Product Picture of Transcranial Magnetic Stimulation
Figure 15. Product Picture of Transcutaneous Electrical Stimulation
Figure 16. Product Picture of Other
Figure 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type in 2022
Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2018-2023)
Figure 19. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Parkinson's Disease
Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Parkinson's Disease (2018-2023) & (Unit)
Figure 21. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Epilepsy
Figure 22. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Epilepsy (2018-2023) & (Unit)
Figure 23. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Pain
Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Pain (2018-2023) & (Unit)
Figure 25. Neuromodulation Devices and Implantable Infusion Pumps Consumed in Other
Figure 26. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Other (2018-2023) & (Unit)
Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2022)
Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application in 2022
Figure 29. Neuromodulation Devices and Implantable Infusion Pumps Sales Market by Company in 2022 (Unit)
Figure 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Company in 2022
Figure 31. Neuromodulation Devices and Implantable Infusion Pumps Revenue Market by Company in 2022 ($ Million)
Figure 32. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Company in 2022
Figure 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Geographic Region (2018-2023)
Figure 34. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Geographic Region in 2022
Figure 35. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales 2018-2023 (Unit)
Figure 36. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue 2018-2023 ($ Millions)
Figure 37. APAC Neuromodulation Devices and Implantable Infusion Pumps Sales 2018-2023 (Unit)
Figure 38. APAC Neuromodulation Devices and Implantable Infusion Pumps Revenue 2018-2023 ($ Millions)
Figure 39. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales 2018-2023 (Unit)
Figure 40. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue 2018-2023 ($ Millions)
Figure 41. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales 2018-2023 (Unit)
Figure 42. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue 2018-2023 ($ Millions)
Figure 43. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country in 2022
Figure 44. Americas Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country in 2022
Figure 45. Americas Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2018-2023)
Figure 46. Americas Neuromodulation Devic
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs